You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
|
---|---|
Published in |
Breast Cancer Research, February 2012
|
DOI | 10.1186/bcr3114 |
Pubmed ID | |
Authors |
François-Clément Bidard, David Hajage, Thomas Bachelot, Suzette Delaloge, Etienne Brain, Mario Campone, Paul Cottu, Philippe Beuzeboc, Emilie Rolland, Claire Mathiot, Jean-Yves Pierga |
Abstract |
Circulating tumor cells (CTC) have been recently proposed as a new dynamic blood marker whose positivity at baseline is a prognostic factor and whose changes under treatment are correlated with progression-free survival (PFS) in metastatic breast cancer patients. However, serum marker levels are also used for the same purpose, and no clear comparison has been reported to date. |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 2% |
Netherlands | 1 | 1% |
Turkey | 1 | 1% |
Saudi Arabia | 1 | 1% |
Kenya | 1 | 1% |
Unknown | 81 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 20 | 23% |
Researcher | 17 | 20% |
Student > Master | 8 | 9% |
Student > Postgraduate | 7 | 8% |
Student > Doctoral Student | 6 | 7% |
Other | 18 | 21% |
Unknown | 11 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 37% |
Agricultural and Biological Sciences | 16 | 18% |
Biochemistry, Genetics and Molecular Biology | 10 | 11% |
Engineering | 4 | 5% |
Nursing and Health Professions | 3 | 3% |
Other | 4 | 5% |
Unknown | 18 | 21% |